These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1432613)

  • 1. Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.
    Plusquellec Y; Barre J; de Biasi J; Trenque T; Tillement JP; Houin G
    J Pharm Sci; 1992 Oct; 81(10):1020-3. PubMed ID: 1432613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug recirculation model with multiple cycles occurring at unequal time intervals.
    Plusquellec Y; Houin G
    J Biomed Eng; 1992 Nov; 14(6):521-6. PubMed ID: 1434577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.
    Plusquellec Y; Houin G
    Med Eng Phys; 1995 Apr; 17(3):172-6. PubMed ID: 7795853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear pharmacokinetics of a new inotropic agent.
    Trenque T; Barre J; Lamiable D; Tillement JP
    Arzneimittelforschung; 1994 Apr; 44(4):471-3. PubMed ID: 8010998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats.
    Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G
    Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of lonidamine in rats: evidence of enterohepatic recycling.
    Besner JG; Leclaire R; Roy JJ
    Drug Metab Rev; 1997; 29(1-2):219-34. PubMed ID: 9187520
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs.
    Uemura Y; Tanaka S; Ida S; Yuzuriha T
    J Pharm Pharmacol; 1993 Dec; 45(12):1077-81. PubMed ID: 7908977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterohepatic circulation model for population pharmacokinetic analysis.
    Funaki T
    J Pharm Pharmacol; 1999 Oct; 51(10):1143-8. PubMed ID: 10579685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic model for the enterohepatic circulation of mycophenolic acid].
    Jiao Z; Shen J; Zhong LJ; Yu YQ; Zhong MK
    Yao Xue Xue Bao; 2006 Mar; 41(3):272-6. PubMed ID: 16759002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2003 Jul; 184(1):69-99. PubMed ID: 12788234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations.
    Snoeck E; Piotrovskij V; Jacqmin P; Lins RL; Van Peer A; Danhof M; Woestenborghs R; Van Gool R; Dupont AG; Heykants J
    Eur J Clin Pharmacol; 1997; 53(1):57-63. PubMed ID: 9349931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
    Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
    Peng B; Dutreix C; Mehring G; Hayes MJ; Ben-Am M; Seiberling M; Pokorny R; Capdeville R; Lloyd P
    J Clin Pharmacol; 2004 Feb; 44(2):158-62. PubMed ID: 14747424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 3rd communication: whole-body autoradiographic study in Cynomolgus monkeys after oral administration.
    Benard P; Dormard Y; Houin G; Declume C; Malbosc R; Tufenkji AE; Galtier P; Alvinerie M
    Arzneimittelforschung; 1993 May; 43(5):516-20. PubMed ID: 8328994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 2nd communication: tissue distribution in rats.
    Atabakhsh F; Benard P; Declume C; Tufenkji AE; Malbosc R; Campistron G; Houin G
    Arzneimittelforschung; 1993 Apr; 43(4):436-40. PubMed ID: 8494573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic model for enterohepatic recirculation in the rat: phenolphthalein, a model drug.
    Colburn WA; Hirom PC; Parker RJ; Milburn P
    Drug Metab Dispos; 1979; 7(2):100-2. PubMed ID: 38070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.